Clinical Trials Browser

Phase 2/3 × Colonic Neoplasms × Folfox protocol × Clear all

NCT02882269 2016-08-30

Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer

Phase 2/3 Unknown

Gastrointestinal

Colonic Neoplasms